Floradapt(TM) CARDIO
Natural health product licensed in Canada
- Licence holder
- Kaneka Americas Holding Inc, CA, USA
- NPN or DIN-HM
- 80096187
- Status
- Active licence
- Licence date
- 18 December 2019
- Revision date
- 23 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactiplantibacillus plantarum Source : Cellule entière | 0.4 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : L. plantarum KABP-013 | 0.4 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Phosphate de potassium, monobasique, Trehalose, Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Phosphate de potassium, dibasique, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Helps support healthy cholesterol level in hypercholesterolaemic patients. Helps to reduce levels of total cholesterol in men and women with hypercholesterolemia. Helps to decrease total cholesterol levels in patients with hypercholesterolemia. Helps to improve total cholesterol levels in patients with hypercholesterolemia. Helps to support HDL levels when taken in adjunction with conventional statins therapy. Supportive therapy to hyperlipidemia in adjunction with conventional statins therapy. Supportive therapy to hypercholesterolemia in conjunction with conventional statins therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult a health care practitioner/health care provider/health care professional/ doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
Source
Official Health Canada record, licence 80096187
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.